Lipe & Dalton

SEC CIK: 0001570396
Latest filing: Jul 14, 2026

SEC filings (opens in a new tab)

ABBV holding history

AbbVie Inc. in every 13F filed by Lipe & Dalton, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overview All 13F holders of ABBV Full Q2 2026 holdings

Shares (Q2 2026): 18,365
Value: $4.62M
% of portfolio: 2.1%
Quarters held: 22; Since Q1 2021

Holdings of ABBV by Lipe & Dalton, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	18,365	$4.62M	2.1%	−250−1.3%	Reduced	Holders
Q1 2026	18,615	$4.05M	2.1%	−590−3.1%	Reduced	Holders
Q4 2025	19,205	$4.39M	2.2%	−595−3.0%	Reduced	Holders
Q3 2025	19,800	$4.58M	2.3%	−4,585−18.8%	Reduced	Holders
Q2 2025	24,385	$4.53M	2.4%	−450−1.8%	Reduced	Holders
Q1 2025	24,835	$5.20M	2.9%	−560−2.2%	Reduced	Holders
Q4 2024	25,395	$4.51M	2.4%	−90−0.4%	Reduced	Holders
Q3 2024	25,485	$5.03M	2.5%	−100−0.4%	Reduced	Holders
Q2 2024	25,585	$4.39M	2.4%	−831−3.1%	Reduced	Holders
Q1 2024	26,416	$4.81M	2.5%	−159−0.6%	Reduced	Holders
Q4 2023	26,575	$4.12M	2.2%	−490−1.8%	Reduced	Holders
Q3 2023	27,065	$4.03M	2.4%	−375−1.4%	Reduced	Holders
Q2 2023	27,440	$3.70M	2.1%	−12,570−31.4%	Reduced	Holders
Q1 2023	40,010	$6.38M	3.7%	−1,499−3.6%	Reduced	Holders
Q4 2022	41,509	$6.71M	3.9%	−773−1.8%	Reduced	Holders
Q3 2022	42,282	$5.67M	3.6%	−248−0.6%	Reduced	Holders
Q2 2022	42,530	$6.51M	3.8%	−674−1.6%	Reduced	Holders
Q1 2022	43,204	$7.00M	3.4%	−1,943−4.3%	Reduced	Holders
Q4 2021	45,147	$6.11M	2.9%	+1,251+2.8%	Added	Holders
Q3 2021	43,896	$4.74M	2.4%	+3,627+9.0%	Added	Holders
Q2 2021	40,269	$4.54M	2.4%	+152+0.4%	Added	Holders
Q1 2021	40,117	$4.34M	2.4%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.